ArticleDiagnostics (Basel, Switzerland)2024

New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Ermina Stratina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.